Vaxcyte (PCVX) market cap

Market cap today
$9.40B

Vaxcyte (PCVX) has a market cap of $9.40B. At the end of fiscal 2025 (December 31, 2025) its market cap was $6.28B. That is 37.1% lower than the $9.99B of fiscal 2024. Today's figure is 49.7% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 07:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$9.40B
Market cap, fiscal 2025
$6.28B
Change on fiscal 2024
−37.1%
Growth, 5 years
+51.6% a year
Highest on record
$9.99Bfiscal 2024
Lowest on record
$785.03Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Vaxcyte market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 51.6% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $9.99B in fiscal 2024 and the lowest $785.03M in fiscal 2020.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Vaxcyte market cap, year by year

Vaxcyte (PCVX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$9.40B—$59.40—
2025$6.28B 37.1% down$46.14136.09M
2024$9.99B 63.7% up$81.86122.00M
2023$6.10B 96.1% up$62.8097.16M
2022$3.11B 151.8% up$47.9564.88M
2021$1.24B 57.3% up$23.7951.92M
2020$785.03M—$26.5729.55M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Vaxcyte and comparable companies
CompanyMarket cap
Avantor AVTR$10.29B
Ensign Group ENSG$10.85B
Vaxcyte PCVX$9.40B
Bio-Rad Laboratories BIO$9.63B
Molina Healthcare MOH$11.55B
Spyre Therapeutics SYRE$8.91B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on PCVX

Vaxcyte, figure by figure

Vaxcyte (PCVX) overview: price, valuation and scorecardAll health care companies by market value

Vaxcyte market cap: questions and answers

What is Vaxcyte's market cap?

Vaxcyte (PCVX) has a market cap of $9.40B. At the end of fiscal 2025 (December 31, 2025) its market cap was $6.28B. That is 37.1% lower than the $9.99B of fiscal 2024.

What is the growth rate of Vaxcyte's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 51.6% a year.

What are the highest and lowest market cap figures on record for Vaxcyte?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $9.99B in fiscal 2024 and the lowest $785.03M in fiscal 2020.

How is Vaxcyte's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vaxcyte (PCVX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/PCVX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.